PPT-Management of patients on anti-coagulant and anti-platelet drugs

Author : singh | Published Date : 2022-06-15

Paige Lipski Overview of coagulation In health components of coagulation all present in circulation and only become activated when injury occurs Injury results in

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Management of patients on anti-coagulant..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Management of patients on anti-coagulant and anti-platelet drugs: Transcript


Paige Lipski Overview of coagulation In health components of coagulation all present in circulation and only become activated when injury occurs Injury results in vasoconstriction to reduce blood loss and assist platelet adhesion. Dr. S. Parthasarathy . MD., DA., DNB, MD (. Acu. ), Dip. . Diab. . DCA, Dip. Software statistics, PhD(physiology). Mahatma Gandhi Medical College and Research Institute, . Puducherry. , India . Definition . Thrombocytes. Platelets (Thrombocytes). 2- 4 micromillimeters in diameter. 250,000 – 400,000 per microliter . (too few thrombocytopenia – too many thrombocytosis). Lifespan on average 6 – 10 days. Joanna Rupa-Matysek. Hemostatic. System - . general. . information. Normal . hemostatic. system . vessel wall. circulating blood platelets. blood coagulation and . fibrynolysis. Bleeding. . Diathesis. Thrombocytes. Platelets (Thrombocytes). 2- 4 micromillimeters in diameter. 250,000 – 400,000 per microliter . (too few thrombocytopenia – too many thrombocytosis). Lifespan on average 6 – 10 days. Jar Testing Made Easy CA-NV AWWA, March 26, 2019 by Guy Schott, P.E. Filterability Floc Strength UVA/%UVT Settleability Dosages Coagulants Sludge Production Jar Test Procedures Keep it simple End of flocculation Physiologically; when platelets are activated, they undergo a sequence of reactions that are essential for hemostasis & important for the healing of damaged blood vessels. These reactions include:. INDICATIONS AND USAGE Treatment of Thrombocytopenia in Patients with Chronic Liver Disease (CLD) DOPTELET is indicated for the treatment of thrombocytopenia in adult patients with chronic liver diseas thrombocytopenia. ) constitutes an important cause of generalized bleeding.. A count less than 100,000 platelets/. μL. is generally considered to constitute thrombocytopenia. . Platelet counts in the range of 20,000 to 50,000 platelets/. At the end of this unit of study, the student should be able to:. Describe the normal morphology and number of platelets on a peripheral blood smear and state the normal life span and concentration of platelets in the blood.. María Carmen Ovejero-Benito, . PhD. covejero@salud.madrid.org. Clinic. . Pharmacology. . Department. Hospital Universitario de La . Princesa. Madrid (. Spain. ). Psoriasis . is. a . clinical. . heterogeneous. Rationale-. . Telangana. Rationale-. Covid-19, has been a major public health concern worldwide. India announced lockdown on 23rd March 2020, which led to halt of all the outpatient services, sample transportation and Anti TB drug delivery.. . Testing. . for. . Neurointerventional. . Procedures. Where. are . we. . now. ?. Josser . E. Delgado, M.D.. Yasha. . Kayan. , M.D.. Neuroscience Institute. Abbott Northwestern Hospital. Consulting Radiologists, Ltd. Ishfaq. . Bukhari. Dec. 2012. In healthy vasculature, circulating platelets are maintained in an inactive state by nitric oxide (NO) and . prostacyclinre. (PGI2)leased by endothelial cells lining the blood vessels.. . Platelet products, . volume . and expected . p. latelet . i. ncrement . Indications for platelet transfusions . Decision to transfuse should be based on both laboratory investigations and assessment of the clinical condition with careful consideration of risks & benefits. .

Download Document

Here is the link to download the presentation.
"Management of patients on anti-coagulant and anti-platelet drugs"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

Related Documents